Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
The 2018 European School of Hematology (ESH) Clinical Updates on Acute Leukemias, held in Budapest, Hungary, took place on the 4–6 May. ESH AL focused on our increased understanding of acute leukemias and the revolutionary new therapies being developed.
Exciting topics from this year’s conference include expert insights into the utility and impact of MRD, problems posed by relapsed/refractory disease, and novel immuno-oncology approaches.
ESH AL 2018
The 2018 European School of Hematology (ESH) Clinical Updates on Acute Leukemias, held in Budapest, Hungary, took place on the 4–6 May. ESH AL focused on our increased understanding of acute leukemias and the revolutionary new therapies being developed.
Exciting topics from this year’s conference include expert insights into the utility and impact of MRD, problems posed by relapsed/refractory disease, and novel immuno-oncology approaches.
